Previous research has demonstrated that hepatic USP14 expression is much higher in NAFLD patients and that hepatic USP14 overexpression exacerbates diet-induced hepatic steatosis, inflammation, and fibrosis in mice, in contrast to the results of hepatic USP14 knockdown (107, 108). The gene discussed is USP14; the disease is metabolic dysfunction-associated steatotic liver disease.